Gupta, Manik K.
Singh, Jasvinder A. http://orcid.org/0000-0003-3485-0006
Article History
First Online: 13 March 2019
Compliance with Ethical Standards
:
: Jasvinder A. Singh has received consultant fees from Crealta/Horizon, Fidia, UBM LLC, Medscape, WebMD, the National Institutes of Health, and the American College of Rheumatology. He owns stock options in Amarin Pharmaceuticals and Viking Therapeutics. He is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. Jasvinder A. Singh is also a member of the Veterans Affairs Rheumatology Field Advisory Committee and is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. Manik K. Gupta has no conflicts of interest that are directly relevant to the content of this article.
: No sources of funding were received for the preparation of this review.